精神心理科指南

订阅

MedSci主页 / 所有栏目 / 精神心理科指南

2018 CFPC循证临床实践指南：苯二氮䓬类受体激动剂处方精简

2018-05-06 加拿大家庭医生学会 Can Fam Physician. 2018 May;64(5):339-351.

苯二氮䓬类受体激动剂处方精简

2018年5月，加拿大家庭医生学会(CFPC)发布了苯二氮䓬类受体激动剂处方精简指南，本文主要帮助临床医师针对何时以及如何安全应用和停用苯二氮䓬类受体激动剂提供指导。

中文标题：

2018 CFPC循证临床实践指南：苯二氮䓬类受体激动剂处方精简

英文标题：

Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline.

发布机构：

加拿大家庭医生学会

发布日期：

2018-05-06

简要介绍：

2018年5月，加拿大家庭医生学会(CFPC)发布了苯二氮䓬类受体激动剂处方精简指南，本文主要帮助临床医师针对何时以及如何安全应用和停用苯二氮䓬类受体激动剂提供指导。 

拓展指南：与处方相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 CFPC循证临床实践指南：苯二氮䓬类受体激动剂处方精简)] GetToolGuiderByIdResponse(projectId=1, id=bc2321c001593195, title=2018 CFPC循证临床实践指南：苯二氮䓬类受体激动剂处方精简, enTitle=Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline., guiderFrom=Can Fam Physician. 2018 May;64(5):339-351., authorId=null, author=, summary=2018年5月，加拿大家庭医生学会(CFPC)发布了苯二氮䓬类受体激动剂处方精简指南，本文主要帮助临床医师针对何时以及如何安全应用和停用苯二氮䓬类受体激动剂提供指导。 , cover=, journalId=null, articlesId=null, associationId=1633, associationName=加拿大家庭医生学会, associationIntro=, copyright=0, guiderPublishedTime=Sun May 06 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年5月，加拿大家庭医生学会(CFPC)发布了苯二氮䓬类受体激动剂处方精简指南，本文主要帮助临床医师针对何时以及如何安全应用和停用苯二氮䓬类受体激动剂提供指导。 </div> <div><br> </div> 拓展指南：<strong>与<font color=red>处方</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=bc2321c001593195" title="2018 CFPC循证临床实践指南：苯二氮䓬类受体激动剂处方精简" target=_blank>2018 CFPC循证临床实践指南：苯二氮䓬类受体激动剂处方精简</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d20dc1c0015e5ae2" title="中成药临床合理用药处方点评北京共识" target=_blank>中成药临床合理用药处方点评北京共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=761871c0015506fd" title="中国2型糖尿病自我管理处方专家共识 （2017年版）" target=_blank>中国2型糖尿病自我管理处方专家共识 （2017年版）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=fdbef1c0015a858a" title="2018 循证临床实践指南：治疗痴呆和失眠行为和心理症状抗精神病药物处方精简" target=_blank>2018 循证临床实践指南：治疗痴呆和失眠行为和心理症状抗精神病药物处方精简</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=506a41c001a514cb" title="处方环节用药错误防范指导原则" target=_blank>处方环节用药错误防范指导原则</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%A4%84%E6%96%B9" target=_blank>有关处方更多指南</a></ul>, tagList=[TagDto(tagId=27707, tagName=苯二氮䓬), TagDto(tagId=101419, tagName=类受体激动剂), TagDto(tagId=69092, tagName=处方精简)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6969, appHits=132, showAppHits=0, pcHits=5575, showPcHits=1705, likes=133, shares=2, comments=7, approvalStatus=1, publishedTime=Fri May 18 23:27:19 CST 2018, publishedTimeString=2018-05-06, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri May 18 23:27:19 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 21:26:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 CFPC循证临床实践指南：苯二氮䓬类受体激动剂处方精简)])
2018 CFPC循证临床实践指南：苯二氮䓬类受体激动剂处方精简
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=316610, encodeId=d5b431661028, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat May 19 10:48:31 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316535, encodeId=47ea31653548, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat May 19 07:28:49 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316498, encodeId=ce3131649853, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat May 19 06:26:55 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316485, encodeId=6f75316485ed, content=学习一下谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat May 19 06:13:35 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316462, encodeId=d66e3164624d, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat May 19 04:55:08 CST 2018, time=2018-05-19, status=1, ipAttribution=)]
    2018-05-19 1ddf0692m34(暂无匿称)

    学习了.长知识

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=316610, encodeId=d5b431661028, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat May 19 10:48:31 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316535, encodeId=47ea31653548, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat May 19 07:28:49 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316498, encodeId=ce3131649853, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat May 19 06:26:55 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316485, encodeId=6f75316485ed, content=学习一下谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat May 19 06:13:35 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316462, encodeId=d66e3164624d, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat May 19 04:55:08 CST 2018, time=2018-05-19, status=1, ipAttribution=)]
    2018-05-19 张新亮1853311252142e2fm

    好文献学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=316610, encodeId=d5b431661028, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat May 19 10:48:31 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316535, encodeId=47ea31653548, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat May 19 07:28:49 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316498, encodeId=ce3131649853, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat May 19 06:26:55 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316485, encodeId=6f75316485ed, content=学习一下谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat May 19 06:13:35 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316462, encodeId=d66e3164624d, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat May 19 04:55:08 CST 2018, time=2018-05-19, status=1, ipAttribution=)]
    2018-05-19 1dd8c52fm63(暂无匿称)

    了解了解.学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=316610, encodeId=d5b431661028, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat May 19 10:48:31 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316535, encodeId=47ea31653548, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat May 19 07:28:49 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316498, encodeId=ce3131649853, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat May 19 06:26:55 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316485, encodeId=6f75316485ed, content=学习一下谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat May 19 06:13:35 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316462, encodeId=d66e3164624d, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat May 19 04:55:08 CST 2018, time=2018-05-19, status=1, ipAttribution=)]
    2018-05-19 三生有幸9135

    学习一下谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=316610, encodeId=d5b431661028, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat May 19 10:48:31 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316535, encodeId=47ea31653548, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat May 19 07:28:49 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316498, encodeId=ce3131649853, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat May 19 06:26:55 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316485, encodeId=6f75316485ed, content=学习一下谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat May 19 06:13:35 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316462, encodeId=d66e3164624d, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat May 19 04:55:08 CST 2018, time=2018-05-19, status=1, ipAttribution=)]
    2018-05-19 131****1460

    学习了受益匪浅

    0